These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms today.If you are looking to day trade, you might want to check out the following stocks. I usually throw these on my watch list and monitor with resistance & support levels.You can also check previous stocks to buy reports- Right Here.
Green Mountain (GMCR), TD Ameritrade (AMTD), E-Trade (ETFC), Computer Programs (CPSI), Chesapeake (CHK) and PharMerica (PMC) were upgraded or downgraded by analysts.
Green Mountain (GMCR), TD Ameritrade (AMTD), E-Trade (ETFC), Computer Programs (CPSI), Chesapeake (CHK) and PharMerica (PMC) were upgraded or downgraded by analysts.
Green Mountain (GMCR) downgraded to Neutral from Overweight at Piper Jaffray.Piper Jaffray downgraded Green Mountain citing reduced sales growth expectations following the company's Q2 results. The firm lowered its price target for shares to $40 from $65.
TD Ameritrade (AMTD) initiated with a Sell at BGB Securities.Target $15.50.
E-Trade (ETFC) initiated with a Sell at BGB Securities.Target $8.50.
Computer Programs (CPSI) downgraded to Neutral from Buy at Citigroup.Citigroup downgraded Computer Programs citing near-term earnings risk and lowered its price target for shares to $63 from $69.
Chesapeake (CHK) upgraded to Outperform from Underperform at Bernstein.Bernstein believes Chesapeake investor sentiment is near a bottom and risk/reward is favorable. Price target raised to $21 from $17.
PharMerica (PMC) upgraded to Outperform from Sector Perform at RBC Capital.RBC Capital upgraded PharMerica based on improving visibility, earnings growth, and relative valuation. Price target raised to $15 from $13.
TD Ameritrade (AMTD) initiated with a Sell at BGB Securities.Target $15.50.
E-Trade (ETFC) initiated with a Sell at BGB Securities.Target $8.50.
Computer Programs (CPSI) downgraded to Neutral from Buy at Citigroup.Citigroup downgraded Computer Programs citing near-term earnings risk and lowered its price target for shares to $63 from $69.
Chesapeake (CHK) upgraded to Outperform from Underperform at Bernstein.Bernstein believes Chesapeake investor sentiment is near a bottom and risk/reward is favorable. Price target raised to $21 from $17.
PharMerica (PMC) upgraded to Outperform from Sector Perform at RBC Capital.RBC Capital upgraded PharMerica based on improving visibility, earnings growth, and relative valuation. Price target raised to $15 from $13.
For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com/
